CGTX Stock Analysis: Buy, Sell, or Hold?
CGTX - Cognition Therapeutics, Inc. Common Stock
$1.09
-0.15 (-12.10%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When CGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CGTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CGTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CGTX is currently trading at $1.09, which is considered oversold relative to its 30-day fair value range of $1.31 to $1.49.
Technical Outlook: Technically, CGTX is in a strong uptrend. The price is currently testing key support at $1.07. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 12.1% recently.
Market Sentiment: CGTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.50 (+221.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CGTX is in a strong uptrend. The price is currently testing key support at $1.07. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 12.1% recently.
Market Sentiment: CGTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.50 (+221.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.31 -
$1.49
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding CGTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-12.1%)
- BULLISH: Trading 221.1% below Wall St target ($3.50)
- CAUTION: 5-day price weakness (-23.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.31 -
$1.49
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.08
Resistance Level
$1.51
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.25
Wall Street Target
$3.50
(+221.1%)
Last updated: February 01, 2026 6:33 AM ET
Data refreshes hourly during market hours. Next update: 7:33 AM
Data refreshes hourly during market hours. Next update: 7:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
Advanced CGTX Option Strategies
Professional options setups generated by AI based on today's CGTX price and gamma walls.
